THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT

年龄相关记忆障碍的遗传学和功能神经解剖学

• 批准号: 7717960
• 负责人: GARY William SMALL
• 金额: $ 0.18万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7717960
• 关键词: Age-associated memory impairment; Alzheimer' s Disease; Aricept; Computer Retrieval of Information on Scientific Projects Database; Funding; Genetic; Grant; Individual; Institution; Memory Loss; Memory impairment; Neuroanatomy; Placebos; Purpose; Research; Research Personnel; Resources; Source; United States Food and Drug Administration; United States National Institutes of Health; age related

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this 2-year study is to find out whether Aricept may delay the onset of further age related memory loss. Aricept has been approved by the FDA for the treatment of probable Alzheimer's disease. We are studying individuals with age related memory impairment. Half of the subjects will receive Aricept and half will receive a placebo.

该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项为期2年的研究的目的是找出安理申是否可以延迟进一步的年龄相关的记忆丧失的发作。 Aricept已被FDA批准用于治疗可能的阿尔茨海默病。 我们正在研究与年龄相关的记忆障碍的个体。 一半的受试者将接受Aricept，另一半将接受安慰剂。